Skip to Main Content

Author Details

Mathieu Ghadanfar
Novartis Pharma AG
1991
26
15
PMIDPaper TitleJournal TitlePublished Year
36196060Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF.Eur J Heart Fail2023
37649316Hospitalization for acute heart failure during non-working hours impacts on long-term mortality: the REPORT-HF registry.ESC Heart Fail2023
37678961Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry.JACC Heart Fail2023
37973338Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study.Lancet Glob Health2023
36974770Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF.Eur J Heart Fail2023
34516969A global perspective of racial differences and outcomes in patients presenting with acute heart failure.Am Heart J2022
35429091Quality of life assessed 6â¿¿months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure).Eur J Heart Fail2022
35393622Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction.Eur Heart J2022
35064730Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry.Eur J Heart Fail2022
33839078Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HF.JACC Heart Fail2021
32710857Correction to: Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study.Lancet Glob Health2020
32087174Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study.Lancet Glob Health2020
31913404Global Differences in Characteristics, Precipitants, and Initial Management of Patients Presenting With Acute Heart Failure.JAMA Cardiol2020
25754836International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry.Eur J Heart Fail2015
19145003Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.Nephrol Dial Transplant2009
19323611Physicians' attitudes and adherence to use of risk scores for primary prevention of cardiovascular disease: cross-sectional survey in three world regions.Curr Med Res Opin2009
16480976Class III effects of dofetilide and arrhythmias are modulated by [K+]o in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardium.Eur J Pharmacol2006
15542282Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study.J Am Coll Cardiol2004
11824857Amlodipine versus chlorthalidone versus placebo in the treatment of stage I isolated systolic hypertension.Am J Hypertens2002
11377349Cardiac and hemodynamic effects of intravenous dofetilide in patients with heart failure.Am J Cardiol2001
10618309Electrophysiological effects of dofetilide in an in vitro model of "border zone" between normal and ischemic/reperfused myocardium.Circulation2000
10750127Steady-state versus non-steady-state QT-RR relationships in 24-hour Holter recordings.Pacing Clin Electrophysiol2000
9757155Dynamic analysis of dofetilide-induced changes in ventricular repolarization.Clin Pharmacol Ther1998
8840849Influence of dofetilide on QT-interval duration and dispersion at various heart rates during exercise in humans.Circulation1996
7768076Pharmacokinetic and pharmacodynamic modeling of the effects of oral and intravenous administrations of dofetilide on ventricular repolarization.Clin Pharmacol Ther1995
1859147[Unstable angina and infarction without Q wave treated with verapamil: value of the early exercise test].Ann Cardiol Angeiol (Paris)1991
  • 1 - 26 of 26

Recommended Authors

Marat Fudim
Duke University Medical Center, Duke Clinical Research Institute
Career Start Year 2010
Number of shared co-authors 2
Ravi V Desai
Gladstone Institutes
Career Start Year 2004
Number of shared co-authors 2
Akshay S Desai
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2003
Number of shared co-authors 6
Adrian F Hernandez
Duke University Medical Center
Career Start Year 2003
Number of shared co-authors 10
Peter A Noseworthy
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 1
Eric J Velazquez
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 7
Samir Saba
University of Pittsburgh, PA University of Pittsburgh Medical Center
Career Start Year 1999
Number of shared co-authors 2
Benjamin M Scirica
Brigham and Women's Hospital
Career Start Year 1998
Number of shared co-authors 2
Robert L McNamara
Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 1
Frederick A Masoudi
University of Colorado School of Medicine
Career Start Year 1994
Number of shared co-authors 3
Gary Michael Felker
Duke University School of Medicine
Career Start Year 1992
Number of shared co-authors 10
R. Scott Wright
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 0
Ali Serdar Fak
Marmara University, Hypertension and Atherosclerosis Research Center
Career Start Year 1992
Number of shared co-authors 0
Gregg C Fonarow
David Geffen School of Medicine, University of California, Los Angeles Medical Center
Career Start Year 1992
Number of shared co-authors 9
John R Teerlink
Cardiology University of California San Francisco (UCSF)
Career Start Year 1991
Number of shared co-authors 11
William T Abraham
The Ohio State University
Career Start Year 1990
Number of shared co-authors 9
Alexandre Mebazaa
INSERM UMR-S , Universite de Paris Cite
Career Start Year 1989
Number of shared co-authors 11
Burkert Pieske
Charite University Medicine, Berlin Institute of Health (BIH)
Career Start Year 1988
Number of shared co-authors 10
Shawn W Robinson
University of Maryland
Career Start Year 1986
Number of shared co-authors 0
Jalal K Ghali
Department of Medicine Morehouse School of Medicine Atlanta GE.
Career Start Year 1985
Number of shared co-authors 5
Kent R Bailey
Mayo Clinic
Career Start Year 1983
Number of shared co-authors 0
Ileana L Pi??a
Thomas Jefferson University
Career Start Year 1980
Number of shared co-authors 8
JoAnn Lindenfeld
Vanderbilt University Medical Center
Career Start Year 1980
Number of shared co-authors 9
Robert M Califf
From the National Institutes of Health
Career Start Year 1978
Number of shared co-authors 5
Michel Komajda
Saint Joseph Hospital, Paris-Sorbonne University
Career Start Year 1978
Number of shared co-authors 11
Paul Erne
Biostatistics and Prevention Institute, University of Zurich
Career Start Year 1976
Number of shared co-authors 3
Philip T Sager
Inc., Canada Cardiovascular Research Institute, Stanford University
Career Start Year 1975
Number of shared co-authors 0
Dimitrios Th Kremastinos
National and Kapodistrian University of Athens
Career Start Year 1973
Number of shared co-authors 6
Bernard J Gersh
Mayo Clinic College of Medicine and Science
Career Start Year 1969
Number of shared co-authors 4
Alan S Go
Kaiser Permanente Northern California
Career Start Year 1962
Number of shared co-authors 2

Collaborators

Gerasimos Filippatos
National and Kapodistrian University of Athens, Attikon University Hospital
Co-authored papers 14
Kenneth Dickstein
University of Bergen
Co-authored papers 14
Ulf Dahlstr??m
Linkoping University
Co-authored papers 14
Georg Ertl
University Hospital Wurzburg
Co-authored papers 14
Achim Obergfell
Novartis Pharma
Co-authored papers 13
Carolyn S P Lam
Duke-NUS Medical School
Co-authored papers 13
Mahmoud Hassanein
Alexandria University
Co-authored papers 13
Sean P Collins
Vanderbilt University School of Medicine
Co-authored papers 13
John G F Cleland
British Heart Foundation Centre of Research Excellence, University of Glasgow
Co-authored papers 13
Christiane E Angermann
University and University Hospital Wurzburg
Co-authored papers 12
Anja Schweizer
Novartis Pharma AG
Co-authored papers 11
Sergio V Perrone
El Cruce Hospital by Florencio Varela, Lezica Cardiovascular Institute
Co-authored papers 10
Wan Ting Tay
Co-authored papers 4
Candace D McNaughton
University of Toronto
Co-authored papers 1
Tadhg Guerin
Novartis Ireland Ltd
Co-authored papers 1
Mihai Gheorghiade
Bluhm Cardiovascular Institute, Northwestern University Feingerg School of Medicine
Co-authored papers 1
Christopher J Lindsell
Duke University
Co-authored papers 1
Kimberly W Hart
Vanderbilt University Medical Center
Co-authored papers 1
John A Spertus
University of Missouri-Kansas City School of Medicine
Co-authored papers 1
Release 1.2